Cocaine-and amphetamine-related transcript (CART) is a neuropeptide first discovered in
the striatum of the rat brain. Later, the genetic sequence and function of CART peptide …

The hypothalamus is part of the diencephalon and has several nuclei, one of which is the
arcuate nucleus. The arcuate nucleus of hypothalamus (ARH) consists of neuroendocrine …

Cocaine and amphetamine-regulated transcript peptide (CARTp) is an anorexigenic
neuropeptide whose receptor is undisclosed. Previously, we reported the specific binding of …

The endogenous ligands activating a large fraction of the G Protein Coupled Receptor
(GPCR) family members have yet to be identified. These receptors are commonly labeled as …

The intensity of muscle contraction, and therefore movement vigor, needs to be adaptable to
enable complex motor behaviors. This can be achieved by adjusting the properties of motor …

The g-protein coupled receptor GPR-160, recently identified as a putative receptor for the
cocaine and amphetamine-regulated transcript (CART) peptide, shows abundant …

The existence of the peptide encoded by the cocaine-and amphetamine-regulated transcript
(Cartpt) has been recognized since 1981, but it was not until 1995, that the gene encoding …

Neuropeptides and G protein‐coupled receptors (GPCRs) have long been, and continue to
be, one of the most popular target classes for drug discovery in CNS disorders, including …

Cocaine-and amphetamine-regulated transcript encodes an eponymous peptide, CARTp,
which exerts diverse pharmacologic actions in the central and peripheral nervous systems …

Cocaine and amphetamine-regulated transcript (CART) is expressed in pancreatic islet cells
and neuronal elements. We have previously established insulinotropic actions of CART in …